These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11682630)

  • 1. Critical residues for the specificity of cofactors and substrates in human estrogenic 17beta-hydroxysteroid dehydrogenase 1: variants designed from the three-dimensional structure of the enzyme.
    Huang YW; Pineau I; Chang HJ; Azzi A; Bellemare V; Laberge S; Lin SX
    Mol Endocrinol; 2001 Nov; 15(11):2010-20. PubMed ID: 11682630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical analyses and molecular modeling explain the functional loss of 17β-hydroxysteroid dehydrogenase 3 mutant G133R in three Tunisian patients with 46, XY Disorders of Sex Development.
    Engeli RT; Rhouma BB; Sager CP; Tsachaki M; Birk J; Fakhfakh F; Keskes L; Belguith N; Odermatt A
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):147-54. PubMed ID: 26545797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid substitution of arginine 80 in 17beta-hydroxysteroid dehydrogenase type 3 and its effect on NADPH cofactor binding and oxidation/reduction kinetics.
    McKeever BM; Hawkins BK; Geissler WM; Wu L; Sheridan RP; Mosley RT; Andersson S
    Biochim Biophys Acta; 2002 Nov; 1601(1):29-37. PubMed ID: 12429500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The arginine 276 anchor for NADP(H) dictates fluorescence kinetic transients in 3 alpha-hydroxysteroid dehydrogenase, a representative aldo-keto reductase.
    Ratnam K; Ma H; Penning TM
    Biochemistry; 1999 Jun; 38(24):7856-64. PubMed ID: 10387026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human oestrogenic 17beta-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction.
    Gangloff A; Garneau A; Huang YW; Yang F; Lin SX
    Biochem J; 2001 May; 356(Pt 1):269-76. PubMed ID: 11336660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual charge stabilization of NADP+ in 17beta-hydroxysteroid dehydrogenase.
    Mazza C; Breton R; Housset D; Fontecilla-Camps JC
    J Biol Chem; 1998 Apr; 273(14):8145-52. PubMed ID: 9525918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme specificity in fungal 17beta-hydroxysteroid dehydrogenase.
    Kristan K; Stojan J; Möller G; Adamski J; Rizner TL
    Mol Cell Endocrinol; 2005 Sep; 241(1-2):80-7. PubMed ID: 15998565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Engineering of an Artificially Generated NADP
    Hayashi J; Seto T; Akita H; Watanabe M; Hoshino T; Yoneda K; Ohshima T; Sakuraba H
    Appl Environ Microbiol; 2017 Jun; 83(11):. PubMed ID: 28363957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human estrogenic 17beta-hydroxysteroid dehydrogenase: predominance of estrone reduction and its induction by NADPH.
    Jin JZ; Lin SX
    Biochem Biophys Res Commun; 1999 Jun; 259(2):489-93. PubMed ID: 10362535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. At5g50600 encodes a member of the short-chain dehydrogenase reductase superfamily with 11beta- and 17beta-hydroxysteroid dehydrogenase activities associated with Arabidopsis thaliana seed oil bodies.
    d'Andréa S; Canonge M; Beopoulos A; Jolivet P; Hartmann MA; Miquel M; Lepiniec L; Chardot T
    Biochimie; 2007 Feb; 89(2):222-9. PubMed ID: 17074428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of human 17β-hydroxysteroid dehydrogenase type 1 complexed with estrone and NADP
    Li T; Stephen P; Zhu DW; Shi R; Lin SX
    FEBS J; 2019 Jun; 286(11):2155-2166. PubMed ID: 30768851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of estrogen recognition and 17-keto reduction by human 17beta-hydroxysteroid dehydrogenase 1.
    Ghosh D; Vihko P
    Chem Biol Interact; 2001 Jan; 130-132(1-3):637-50. PubMed ID: 11306082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the substrate inhibition of human 17β-hydroxysteroid dehydrogenase type 1.
    Li T; Song X; Stephen P; Yin H; Lin SX
    J Steroid Biochem Mol Biol; 2023 Apr; 228():106246. PubMed ID: 36634828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an arginine residue in the dual coenzyme-specific glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides that plays a key role in binding NADP+ but not NAD+.
    Levy HR; Vought VE; Yin X; Adams MJ
    Arch Biochem Biophys; 1996 Feb; 326(1):145-51. PubMed ID: 8579362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors.
    Breton R; Housset D; Mazza C; Fontecilla-Camps JC
    Structure; 1996 Aug; 4(8):905-15. PubMed ID: 8805577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate-115 renders specificity of human 11beta-hydroxysteroid dehydrogenase type 2 for the cofactor NAD+.
    Arnold P; Tam S; Yan L; Baker ME; Frey FJ; Odermatt A
    Mol Cell Endocrinol; 2003 Mar; 201(1-2):177-87. PubMed ID: 12706305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-engineering the discrimination between the oxidized coenzymes NAD+ and NADP+ in clostridial glutamate dehydrogenase and a thorough reappraisal of the coenzyme specificity of the wild-type enzyme.
    Capone M; Scanlon D; Griffin J; Engel PC
    FEBS J; 2011 Jul; 278(14):2460-8. PubMed ID: 21564547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde reductase: the role of C-terminal residues in defining substrate and cofactor specificities.
    Rees-Milton KJ; Jia Z; Green NC; Bhatia M; El-Kabbani O; Flynn TG
    Arch Biochem Biophys; 1998 Jul; 355(2):137-44. PubMed ID: 9675019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure/function aspects of human 3beta-hydroxysteroid dehydrogenase.
    Thomas JL; Duax WL; Addlagatta A; Kacsoh B; Brandt SE; Norris WB
    Mol Cell Endocrinol; 2004 Feb; 215(1-2):73-82. PubMed ID: 15026177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural determinants of nucleotide coenzyme specificity in the distinctive dinucleotide binding fold of HMG-CoA reductase from Pseudomonas mevalonii.
    Friesen JA; Lawrence CM; Stauffacher CV; Rodwell VW
    Biochemistry; 1996 Sep; 35(37):11945-50. PubMed ID: 8810898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.